NOTE: News organizations may not keep articles permanently on their sites. As a result, links to news items that have expired may not work.

2012

March

Julie Ross, Ph.D., Prevention and Etiology Program, was interviewed on Minnesota Public Radio about a $1.35 million grant from the Minnesota Partnership for Biotechnology and Medical Genomics that will be shared by the University of Minnesota and Mayo Clinic in order to study myelodysplastic syndrome. Ross, one of the grant's co-PIs, and Masonic Cancer Center member Erica Warlick, M.D., received a $2.5 million grant from the NIH to study the disease last year. Read more.

John Ohlfest, Ph.D., Tumor Microenvironment and Immunology Programs, and Christopher Moertel, M.D., clinical director of the Pediatric Brain Tumor Program, were interviewed on KARE 11Saturday about the May neuro-oncology symposium and the groundbreaking brain tumor therapy being conducted at the University of Minnesota. Watch the video.

Jatinder Lamba, Ph.D., Genetic Mechanisms of Cancer Program, was interviewed about her research on pharmacogenomics in acute myeloid leukemia for an upcoming issue of International Innovations, the leading global resource dedicated to disseminating the latest science, research and technological innovations. The journal will also have an article highlighting the research of her laboratory. To read more click here (PDF).

February

David Rothenberger, M.D., was quoted in New York Times and Star Tribune stories about a new study that confirms that colonoscopy screening reduces cancer mortality in patients with precancerous polyps by 53 percent. Read more.

Jean Forster, Ph.D., M.P.H., School of Public Health and Masonic Cancer Center, explains how three doctoral students and three post-graduates will have the opportunity to study new ways to combat cancer-related health disparities with the money from a $2.2 million federal grant. Read in the Star Tribune

Cancer Center members Nelson Rhodus, D.M.D., M.P.H., and Timothy Griffin, Ph.D., were featured in a UMNews story about their testing saliva for biomarkers for certain cancers. Read more.

January

Judith Berman, Ph.D., Genetic Mechanisms of Cancer Program member, was quote in a story in the journal Science on a recent study showing that gaining or losing a chromosome, a condition known as aneuploidy, is often caused by stress. Read more.

Timothy Church, Ph.D., Prevention and Etiology Program, discussed the results of a study conducted by University of Minnesota researchers including Timothy Wilt, M.D., confirming that PSA blood test screening for prostate cancer did not reduce men's risk of dying from the disease. Read more in MinnPost.

Research by Mark Distefano, Ph.D., Carcinogenesis and Chemoprevention Program member, was featured in the January issue of Research:people, process, practic@the U of M, published by the Office of the Vice-President of Research.

Reuben Harris, Ph.D., Genetic Mechanisms of Cancer Program, is mentioned in a Leader-Post story about a collaborative effort to find new drug and treatment therapies for the HIV virus.

John Wagner, M.D., co-leader of the Transplant Biology and Therapy Program and director of the Division of Hematology-Oncology and Blood and Marrow Transplantation at a the University of Minnesota Medical School, was quoted in a American Medical Association News story about the judicial ruling that offering financial incentives to encourage people to donate bone marrow cells is legal.

DeAnn Lazovich, Ph.D., M.P.H., co-leader of the Prevention and Etiology Program, was quoted in the Star Tribune article about the state of Minnesota's tax on tanning salons.

Dorothy Hatsukami, Ph.D., associate director of Cancer Prevention and Control, was mentioned in a Small Cap Network article about recent studies that focus on smoking cessation.